Carvalho Filomena A, Almeida José Pedro, Fernandes Isabel O, Freitas-Santos Teresa, Saldanha Carlota
Institute of Biochemistry, Institute of Molecular Medicine, University of Lisbon Medical School, Lisbon, Portugal.
Clin Hemorheol Microcirc. 2008;40(3):207-27.
Non-neuronal acetylcholine (ACh) and acetylcholinesterase (AChE) have been recognized in the past. Vascular ACh has been associated by us with the regulation of microcirculatory flow by modulating nitric oxide (NO) intracellular mobilization, metabolism (NOx) and release from erythrocytes, as well as the glycolytic flux. Velnacrine maleate is a well-known AChE inhibitor which plays a competitive role by decreasing NO-mediated erythrocyte responses. A plausible hypothesis to explain the mechanisms underlying those events hinges on the NO translocation among nitrosylated molecules and phosphorylated/dephosphorylated states of band 3 protein, processed by major tyrosine-kinases (PTK: p72syk, p53/56lyn and p59/61hck) and phosphotyrosine-phosphatases (PTP).
To assess this hypothesis under the influence of AChE effectors (acetylcholine/velnacrine), blood samples from healthy donors were harvested and Western blot analysis was subsequently used to determine the degree of band 3 phosphorylation, in the presence and absence of PTK/PTP inhibitors. NO and nitrites/nitrates were quantified using an amperometric method and the Griess Reaction, respectively, in erythrocyte suspensions. Measurements of erythrocyte metabolites (2,3-bisphosphoglycerate; glyceraldehyde 3-phosphate dehydrogenase; glucose-6-phosphodehydrogenase; lactate), hemoglobin and cyclic nucleotides were conducted afterwards.
Increased levels of phosphorylated-band 3 obtained upon p72syk inhibition suggest p59/61hck and p53/56lyn as secondary involved kinases. As to NO/NOx quantification, in the presence of PTKi we reported higher levels with velnacrine-AChE, as opposed to acetylcholine-AChE. Calpeptin, a PTP inhibitor which triggers full band 3-phosphorylation, led to the opposite NO mobilization, being reinforced by ACh. Oxy-hemoglobin, glyceraldehyde 3-phosphate dehydrogenase and glucose-6-phosphodehydrogenase were found to decrease with ACh, whereas P50, lactate and both cGMP/cAMP happened to increase.
Changes on human erythrocyte NOx mobilization and metabolic fluxes occur under influence of non-neuronal ACh/AChE, in turn dependent on the degree of band 3-phosphorylation. Since these vascular events may potentially change under pathological conditions, coadjuvant drugs could become accessible in the setting of microcirculation disease.
过去已认识到非神经元乙酰胆碱(ACh)和乙酰胆碱酯酶(AChE)。我们发现血管ACh通过调节一氧化氮(NO)的细胞内动员、代谢(NOx)以及从红细胞中的释放,以及糖酵解通量,与微循环血流调节相关。马来酸韦那克林是一种著名的AChE抑制剂,它通过降低NO介导的红细胞反应发挥竞争作用。一个解释这些事件潜在机制的合理假说是基于NO在亚硝基化分子之间的转运以及带3蛋白的磷酸化/去磷酸化状态,这一过程由主要的酪氨酸激酶(PTK:p72syk、p53/56lyn和p59/61hck)和磷酸酪氨酸磷酸酶(PTP)处理。
为了在AChE效应物(乙酰胆碱/韦那克林)的影响下评估这一假说,采集了健康供体的血样,随后使用蛋白质免疫印迹分析来确定在有和没有PTK/PTP抑制剂存在的情况下带3磷酸化的程度。分别使用电流分析法和格里斯反应对红细胞悬液中的NO以及亚硝酸盐/硝酸盐进行定量。之后对红细胞代谢物(2,3-二磷酸甘油酸;甘油醛-3-磷酸脱氢酶;葡萄糖-6-磷酸脱氢酶;乳酸)、血红蛋白和环核苷酸进行测量。
p72syk抑制后获得的带3磷酸化水平升高表明p59/61hck和p53/56lyn为次要参与的激酶。至于NO/NOx定量,在存在PTKi的情况下,我们发现与乙酰胆碱-AChE相比,韦那克林-AChE导致更高的水平。钙蛋白酶抑制剂卡尔肽可触发带3完全磷酸化,导致相反的NO动员,且ACh可增强这种作用。发现氧合血红蛋白、甘油醛-3-磷酸脱氢酶和葡萄糖-6-磷酸脱氢酶随ACh减少,而P50、乳酸以及cGMP/cAMP均增加。
在非神经元ACh/AChE的影响下,人类红细胞NOx动员和代谢通量会发生变化,这又取决于带3磷酸化的程度。由于这些血管事件在病理条件下可能会发生潜在变化,辅助药物在微循环疾病的情况下可能会变得可用。